CME Group Inc. (NASDAQ:CME) Receives $291.81 Average Price Target from Analysts

Posted by Geri Gentry on Aug 17th, 2026

CME Group Inc. (NASDAQ:CME – Get Free Report) has been given a consensus rating of “Hold” by the eighteen ratings firms that are covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $291.8125.

CME has been the subject of a number of analyst reports. Piper Sandler cut their price objective on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research report on Wednesday, July 15th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and raised their target price for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Barclays lowered their target price on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research note on Thursday, July 9th. Raymond James Financial reiterated an “outperform” rating and issued a $320.00 price target on shares of CME Group in a report on Thursday, July 2nd. Finally, The Goldman Sachs Group reduced their price target on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research note on Tuesday, June 30th.

View Our Latest Research Report on CME

CME Group Stock Performance

Shares of CME stock opened at $269.80 on Wednesday. The firm has a 50-day moving average price of $250.20 and a 200 day moving average price of $280.19. CME Group has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a market capitalization of $97.01 billion, a price-to-earnings ratio of 22.88, a PEG ratio of 3.14 and a beta of 0.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm’s quarterly revenue was up .8% on a year-over-year basis. During the same period in the prior year, the firm earned $2.96 EPS. Research analysts forecast that CME Group will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio is presently 44.11%.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard bought 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This represents a 0.12% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Bridgewater Advisors Inc. purchased a new stake in CME Group in the 2nd quarter worth about $612,000. FLC Capital Advisors purchased a new position in CME Group during the 4th quarter valued at about $2,122,000. HighTower Advisors LLC grew its stake in CME Group by 6.9% during the 4th quarter. HighTower Advisors LLC now owns 352,922 shares of the financial services provider’s stock valued at $96,376,000 after acquiring an additional 22,692 shares in the last quarter. MOKAN Wealth Management Inc. increased its holdings in shares of CME Group by 138.8% in the 4th quarter. MOKAN Wealth Management Inc. now owns 7,144 shares of the financial services provider’s stock valued at $1,953,000 after purchasing an additional 4,152 shares during the period. Finally, North Dakota State Investment Board acquired a new position in shares of CME Group in the 4th quarter valued at about $3,368,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

About CME Group

(Get Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.